BTN3A: A Promising Immune Checkpoint for Cancer Prognosis and Treatment

por Kone, Abdou-samad, Ait Ssi, Saadia, Sahraoui, Souha, Badou, Abdallah
Publicado 2022

Prognostic Gene Expression Signature in Patients With Distinct Glioma Grades

por Ait Ssi, Saadia, Chraa, Dounia, El Azhary, Khadija, Sahraoui, Souha, Olive, Daniel, Badou, Abdallah
Publicado 2021

A(2A)R as a Prognostic Marker and a Potential Immunotherapy Target in Human Glioma

por Rafii, Soumaya, Ghouzlani, Amina, Naji, Oumayma, Ait Ssi, Saadia, Kandoussi, Sarah, Lakhdar, Abdelhakim, Badou, Abdallah
Publicado 2023

TMIGD2 as a potential therapeutic target in glioma patients

por Boulhen, Chaimae, AIT SSI, Saadia, Benthami, Hamza, Razzouki, Ibtissam, Lakhdar, Abdelhakim, Karkouri, Mehdi, Badou, Abdallah
Publicado 2023